Navigation Links
Boehringer Ingelheim to Purchase Amgen's Fremont (USA) Facility
Date:1/31/2011

SAN FRANCISCO, Jan. 31, 2011 /PRNewswire/ -- Global Real Estate Consultants has helped Boehringer Ingelheim to strengthen their global presence with a new facility in Fremont.

Global Real Estate Consultants was retained by Boehringer Ingelheim to provide insight and transparency in the Fremont commercial real estate market specifically related to their purchase of Amgen Inc's 350,000 sq. ft. state-of-the-art manufacturing facility with pilot plant and process development labs. "We looked for an international tenant representation specialist to help us undertake a real estate acquisition in a new geographical area. We chose Global Real Estate Consultants because we felt that their level of expertise would best represent our interest," states Dr. Maier-Erbacher of Boehringer Ingelheim.

"We provided Boehringer Ingelheim with unrivaled objective information and transparency," says founder and company principal Erich Struzyk. "At the end we were able to provide savings for our client which they initially did not expect. Boehringer Ingelheim especially appreciated the fact that we do not represent landlords and thus avoided the typical conflicts of interest inherent in the brokerage market."

About Boehringer Ingelheim

The Boehringer Ingelheim group is one of the world's 20 leading pharmaceutical companies. Headquartered in Ingelheim, Germany, it operates globally with 142 affiliates in 50 countries and more than 41,500 employees. For over 125 years, the family-owned company has been committed to researching, developing, manufacturing and marketing novel products of high therapeutic value for human and veterinary medicine. In 2009, Boehringer Ingelheim posted net sales of 12.7 billion euro while spending 21% of net sales in its largest business segment, Prescription Medicines, on research and development (http://www.boehringer-ingelheim.com).

About Global Real Estate Consultants

Global Real Estate Consultants (http://www.globalreconsultants.com) offers leading-edge corporate real estate advice, including portfolio, asset, location, transaction and workplace strategies. Global Real Estate Consultants leverages the expertise of global best-in-class resources, including consultants, economic development agencies, municipalities and other key components in order to provide an unrivaled, unbiased, and comprehensive solution. Global Real Estate Consultants has provided solutions that their clients were not able to obtain from any other provider at any price.


'/>"/>
SOURCE Global Real Estate Consultants
Copyright©2010 PR Newswire.
All rights reserved

Related medicine technology :

1. Boehringer Ingelheim to Purchase Amgens Fremont (California) Facility
2. Reportlinker Adds Boehringer Ingelheim GmbH: PharmaVitae Profile
3. Boehringer Ingelheim Initiates Phase III Clinical Trial With Afatinib in Advanced Breast Cancer
4. Boehringer Ingelheims Pradaxa Available in U.S. Pharmacies Starting Wednesday, November 3
5. Results of Boehringer Ingelheim Oral Hepatitis C Protease Inhibitor and Polymerase Inhibitor Combination Phase Ib Trial Shows Rapid Viral Response Without Use of Pegylated Interferon
6. Boehringer Ingelheim and MacroGenics Announce Global Alliance to Discover, Develop and Commercialize DART™-Based Antibody Therapeutics
7. Boehringer Ingelheim Announces Pivotal Phase III Data Showing Linagliptin Reduced Blood Sugar Compared to Placebo in People With Type 2 Diabetes
8. -- Neurocrine Announces a Second Corporate Collaboration Within Twenty-Four Hours -- Neurocrine Biosciences Announces a Worldwide Collaboration With Boehringer Ingelheim to Research and Develop GPR119 Agonists for Type II Diabetes
9. Boehringer Ingelheim Affirms Safety of Telmisartan With an Analysis of 50,000 Patients and Strongly Disagrees With the Publication of Sipahi et al in Lancet Oncology June 2010
10. New Boehringer Ingelheim Science Quest Mobile Laboratory Brings Hands-On Science Education to Priority Connecticut Elementary Schools
11. Reportlinker Adds Boehringer Ingelheim GmbH: PharmaVitae Profile
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:4/28/2016)...  The blood testing market in China ... Information and The Freedonia Group in a recent report.  ... The healthcare research firm said that China ... stations and in improving testing at the provincial level.  ... Blood Testing Market in China , which ...
(Date:4/28/2016)... 2016 , Net Sales of $1.90 billion ... the prior year period, and an increase of 1.2% on ... EPS for the first quarter were $0.52 reported, a decrease ... an increase of 29.9% over the prior year period ... guidance for 2016 Zimmer Biomet Holdings, Inc. (NYSE ...
(Date:4/28/2016)... Oramed Pharmaceuticals Inc. (NASDAQ: ... on the development of oral drug delivery systems, announced today ... conference, presented by Joseph Gunnar & Co. LLC, ... York . Nadav Kidron , CEO of Oramed, ... Presentation Details:   PIONEERS 2016, presented by ...
Breaking Medicine Technology:
(Date:4/28/2016)... (PRWEB) , ... April 28, 2016 , ... ... on the world stage this week. A group of researchers and leaders from ... the Progress of Regenerative Medicine and Its Cultural Impact ” and receive the ...
(Date:4/28/2016)... (PRWEB) , ... April 28, 2016 , ... ... accessories, is proud to partner with AquaShieldUSA, the country's oldest waterproof cast ... clinic and medical supply stores, the largest selection of daily, night, weatherproof and ...
(Date:4/28/2016)... ... April 28, 2016 , ... ... the open availability of a new CDISC standard, Clinical Trial Registry (CTR) ... trials. This innovative standard will make it possible to build applications that ...
(Date:4/28/2016)... ... April 28, 2016 , ... Trinity ... Tobacco-Free Kids, a leading force in the fight to reduce tobacco use and ... policies that can help reduce tobacco use. The initiative brings together two organizations ...
(Date:4/28/2016)... ... 28, 2016 , ... In 2011, TIME magazine named Herr the “Leader of ... technology that marries human physiology with electromechanics. He continues that work as Director of ... of BionX , a leader in the field of prosthetic devices. , After ...
Breaking Medicine News(10 mins):